Semaglutide Beneficial in HFpEF Patients With Diabetes Semaglutide Beneficial in HFpEF Patients With Diabetes
In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology Source Type: news
More News: Cardiology | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Internal Medicine | Obesity | Weight Loss